公众号 / 文章中毒与环境急症

美国国家毒物数据系统年度报告四十年

Forty years of National Poison Data System Annual Reports.
PubMed 文献 · Clin Toxicol (Phila) · 2023-12-12
一句话结论美国国家毒物数据系统(NPDS)四十年来接收全美50个州及领地的毒物暴露数据,近实时采集,可用于毒物监测;芬太尼暴露自2019年快速增加,严重结局病例持续上升。

本文为《临床毒理学》发表的评论文章,回顾美国国家毒物数据系统(NPDS)年度报告四十年变化。NPDS现接收全美50个州及领地的毒物暴露数据,覆盖各级医疗与结局,近实时采集;2022年报告规模为1983年的两倍,来自医疗机构呼叫、故意暴露及死亡的百分比至少翻倍,6岁以下管理病例百分比下降40%。自2008年总报告病例减少,但严重医学结局病例稳步增加。芬太尼暴露自2019年因非处方芬太尼快速增加,总暴露及严重结局与全国芬太尼死亡数据良好相关。作者认为毒物中心数据稳健可重复,支持信息时代继续需要毒物中心。

要点

  • NPDS现接收全美50个州及领地的毒物暴露数据,覆盖各级医疗与结局,近实时采集。
  • 2022年报告规模为1983年的两倍,来自医疗机构呼叫、故意暴露及死亡的百分比至少翻倍,6岁以下管理病例百分比下降40%。
  • 自2008年总报告病例减少,但严重医学结局病例稳步增加。
  • 芬太尼暴露自2019年因非处方芬太尼快速增加,总暴露及严重结局与全国芬太尼死亡数据良好相关,显示NPDS可作监测工具。
  • NPDS优势包括数据库广度、粒度、同期数据采集、近实时提交支持自动毒物监测、快速激活应急产品代码等;劣势包括自愿报告、未核实暴露、结局解读、新疗法数据滞后、死亡率与其他来源不同。

适用人群与场景

  • 美国50个州及领地的毒物暴露人群,覆盖各级医疗与医学结局。
  • 毒物中心数据反映使用毒物中心资源的人群,似乎与其他数据来源趋势一致。

处置流程与药物剂量

  • 为应对较轻病例总数下降,已启动在线工具供消费者获取简单个体化中毒建议,作为直接联系毒物中心的替代方案。

研究设计与关键结果

  • NPDS现接收全美50个州及领地的毒物暴露数据,覆盖各级医疗与结局,近实时采集。
  • 2022年报告规模为1983年的两倍,来自医疗机构呼叫、故意暴露及死亡的百分比至少翻倍,医疗机构管理病例 modest 增加,6岁以下管理病例百分比下降40%。
  • 自2008年总报告病例减少,但严重医学结局病例稳步增加。
  • 芬太尼暴露自2019年因非处方芬太尼快速增加,总暴露及严重结局与全国芬太尼死亡数据良好相关。
  • NPDS死亡模块中芬太尼浓度:死前浓度略低于死后浓度,死后外周与中央浓度差异小,单物质浓度略高于多物质病例。

证据类型、等级与局限

  • 证据类型:评论文章。
  • 局限:原文报告NPDS劣势包括自愿报告、未核实暴露、解读报告的医学结局(非中毒与死亡)、收集新治疗模式数据存在滞后、死亡率数据与其他来源不同。

对床旁实践的改变

  • 作者认为毒物中心数据稳健可重复,似乎反映其他数据来源趋势,支持信息时代继续需要毒物中心以支持潜在毒物暴露患者及严重中毒患者的管理。
  • 在线工具可作为消费者获取简单个体化中毒建议的替代方案,以应对较轻病例总数下降。

指南或共识出处

  • 美国毒物中心第40版国家毒物数据系统年度报告,发表于《临床毒理学》。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: The 40th National Poison Data System Annual Report from America's Poison Centers is published in this issue of Clinical Toxicology. This Commentary will focus on changes that have occurred over the years and emerging trends while highlighting some of the strengths and weaknesses of the system.

FORTY YEARS OF NATIONAL POISON DATA SYSTEM ANNUAL REPORTS: The National Poison Data System now receives poison exposure data from all 50 states and territories of the United States, representing all levels of care and medical outcomes, and is collected in near real-time. The 2022 report is double in size from the 1983 report and shows changes in the distribution of exposure substances and at least a doubling in the percentage of calls from a health care facility, intentional exposures, and fatalities. There was also a more modest increase in cases managed in a health care facility, and a 40% drop in the percentage of cases managed in those under age 6. While total reported poison center cases have been decreasing since 2008, cases with more serious medical outcomes have steadily increased. To address the decline in the total number of less serious cases, an online tool was initiated for consumers to obtain simple individualized poisoning recommendations as an alternative to directly contacting a poison center.

FENTANYL EXPOSURES AND TISSUE CONCENTRATIONS: Fentanyl exposures reported to the National Poison Data System have increased rapidly since 2019, driven by non-prescription fentanyl. Reporting of this was facilitated by the granularity of the generic coding schema and the ability to develop new generic codes rapidly, unlike some other national data sets. Total fentanyl exposures and those with more serious outcomes show a good correlation with national data on fentanyl deaths, demonstrating the ability of the National Poison Data System to function as a surveillance tool. Fentanyl concentrations reported to the National Poison Data System Fatality module showed antemortem concentrations to be slightly lower than postmortem concentrations, little difference between postmortem peripheral and central concentrations, and single substance concentrations slightly higher than cases with multiple substances.

STRENGTHS AND WEAKNESSES: Strengths include the breadth of the database, granularity, contemporaneous data collection, near-real-time data submission allowing for automated toxicosurveillance activities, ability to rapidly activate emergency product codes for emerging situations, a robust web-based query tool, mapping of generic codes and clinical effects to other data dictionaries, and review by toxicologists of fatalities to assign a relative contribution. Weaknesses include voluntarily reported, non-verified exposures, interpreting reported medical outcomes (non-toxic and fatalities), lag-time in collecting data on new therapeutic modalities, and mortality data varying from that reported by other sources.

CONCLUSION: Poison center data gives a robust, reproducible image of the populations that utilize poison center resources and seems to mirror trends noted from other data sources. This supports the continued need for poison centers in the information age to support the management of patients potentially exposed to poisons and those who are more severely poisoned.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Mowry JB. Forty years of National Poison Data System Annual Reports. Clin Toxicol (Phila). 2023. PMID: 38084514. doi:10.1080/15563650.2023.2286200

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。